Safety of Estrogens in Lupus: Hormone Replacement Therapy
Public ClinicalTrials.gov record NCT00000419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether postmenopausal women with systemic lupus erythematosus (SLE, or lupus) can safely use the hormone estrogen. In this part of the study, we will look at the effects of estrogen replacement therapy on the activity and severity of disease in women with SLE.
Study identification
- NCT ID
- NCT00000419
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 1996
- Primary completion
- Not listed
- Completion
- Jul 31, 2002
- Last update posted
- May 2, 2013
1996 – 2002
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Medical Center | Birmingham | Alabama | 35294 | — |
| UCLA Medical Center, Dept. of Rheumatology | Los Angeles | California | 90024 | — |
| University of Chicago Pritzker School of Medicine | Chicago | Illinois | 60637 | — |
| Louisiana School of Medicine | Shreveport | Louisiana | 71130-3932 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21205 | — |
| Univ. of Michigan Med. Ctr., Rheumatology Div. | Ann Arbor | Michigan | 48109-0358 | — |
| Hospital for Joint Diseases | New York | New York | 10003 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Albert Einstein College of Medicine, Jacoby Hospital, Dept. of Rheumatology | The Bronx | New York | 10461 | — |
| UNC Medical Center, Dept. of Rheumatology | Chapel Hill | North Carolina | 27599-7280 | — |
| Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | 73104 | — |
| Univ. of Pennsylvania Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| Univ. of Pittsburgh, Dept. of Rheumatology | Pittsburgh | Pennsylvania | 15213 | — |
| University of Texas Health Sciences Center | Houston | Texas | 77030 | — |
| Medical College of Virginia, Ambulatory Care Center | Richmond | Virginia | 23219 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00000419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 2, 2013 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00000419 live on ClinicalTrials.gov.